Shares of Lannett Company, Inc. (NYSE:LCI) have been assigned an average rating of “Hold” from the nine research firms that are covering the company, MarketBeat reports. Two research analysts have rated the stock with a sell rating and six have assigned a hold rating to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $24.88.

Several research firms recently weighed in on LCI. Zacks Investment Research downgraded Lannett from a “hold” rating to a “strong sell” rating in a report on Wednesday, July 4th. TheStreet downgraded Lannett from a “c-” rating to a “d+” rating in a report on Friday, September 14th. Roth Capital downgraded Lannett from a “buy” rating to a “neutral” rating and lifted their price objective for the company from $23.00 to $27.50 in a report on Monday, August 20th. Raymond James downgraded Lannett from an “outperform” rating to a “market perform” rating and set a $43.00 price objective for the company. in a report on Monday, August 20th. Finally, Craig Hallum downgraded Lannett from a “buy” rating to a “hold” rating in a report on Monday, August 20th.

In related news, Director Patrick G. Lepore bought 25,000 shares of the business’s stock in a transaction on Friday, August 31st. The shares were bought at an average price of $5.34 per share, for a total transaction of $133,500.00. Following the completion of the purchase, the director now directly owns 67,895 shares of the company’s stock, valued at $362,559.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 14.72% of the stock is owned by insiders.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. BlackRock Inc. grew its stake in shares of Lannett by 9.5% during the second quarter. BlackRock Inc. now owns 4,386,677 shares of the company’s stock worth $59,660,000 after acquiring an additional 381,177 shares during the last quarter. Northern Trust Corp grew its stake in shares of Lannett by 36.8% during the first quarter. Northern Trust Corp now owns 800,762 shares of the company’s stock worth $12,852,000 after acquiring an additional 215,228 shares during the last quarter. Heartland Advisors Inc. grew its stake in shares of Lannett by 32.8% during the second quarter. Heartland Advisors Inc. now owns 810,500 shares of the company’s stock worth $11,023,000 after acquiring an additional 200,000 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. grew its stake in shares of Lannett by 350.1% during the second quarter. Connor Clark & Lunn Investment Management Ltd. now owns 219,102 shares of the company’s stock worth $2,980,000 after acquiring an additional 170,425 shares during the last quarter. Finally, KBC Group NV grew its stake in shares of Lannett by 265.8% during the first quarter. KBC Group NV now owns 176,673 shares of the company’s stock worth $2,836,000 after acquiring an additional 128,375 shares during the last quarter. Institutional investors own 97.54% of the company’s stock.

Shares of LCI stock traded up $0.10 on Friday, hitting $4.90. The stock had a trading volume of 18,793 shares, compared to its average volume of 1,735,002. The company has a debt-to-equity ratio of 1.29, a current ratio of 2.62 and a quick ratio of 1.92. The company has a market capitalization of $188.67 million, a P/E ratio of 1.55 and a beta of 2.18. Lannett has a one year low of $4.60 and a one year high of $30.35.

Lannett (NYSE:LCI) last released its quarterly earnings data on Tuesday, August 28th. The company reported $0.64 earnings per share for the quarter, meeting the consensus estimate of $0.64. The firm had revenue of $170.90 million during the quarter, compared to the consensus estimate of $171.21 million. Lannett had a return on equity of 19.92% and a net margin of 4.19%. The firm’s quarterly revenue was up 22.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.40 earnings per share. analysts anticipate that Lannett will post 2.09 earnings per share for the current fiscal year.

Lannett Company Profile

Lannett Company, Inc develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, suspension, soft gel, and injectable dosages.

Featured Story: What is a Leveraged Buyout (LBO)?

Analyst Recommendations for Lannett (NYSE:LCI)

Receive News & Ratings for Lannett Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lannett and related companies with MarketBeat.com's FREE daily email newsletter.